首页> 外国专利> Bacillus amyloliquefaciens K317 for suppressing the growth of antibiotics-resistant pathogenic microorganism or enteropathogenic microorganism

Bacillus amyloliquefaciens K317 for suppressing the growth of antibiotics-resistant pathogenic microorganism or enteropathogenic microorganism

机译:淀粉芽孢杆菌K317,用于抑制耐药性病原微生物或肠道致病微生物的生长

摘要

The present invention relates to a Bacillus amyloliquefaciens K317 strain suppressing the growth of antibiotics-resistant pathogenic microorganisms or enteropathogenic microorganisms, more precisely a Bacillus amyloliquefaciens K317 strain, a culture supernatant thereof and an antibacterial metabolite separated from the same. The Bacillus amyloliquefaciens K317 strain, the culture supernatant thereof and the antibacterial metabolite separated from the same of the invention can be effectively used for the composition, health food, and probiotics for inhibiting the growth of antibiotics-resistant pathogenic microorganisms and enteropathogenic microorganisms, since they have excellent antibacterial activity and inhibition effect on the growth of methicillin resistant pathogenic microorganism and such enteropathogenic microorganism as Edwardsiella tarda, E. coli and Staphylococcus epidermidis.
机译:淀粉芽孢杆菌K317菌株本发明涉及抑制抗生素抗性病原微生物或肠致病性微生物的生长的解淀粉芽孢杆菌K317菌株,更确切地说,涉及一种解淀粉芽孢杆菌K317菌株,其培养上清液和从其分离的抗菌代谢物。由于本发明的解淀粉芽孢杆菌K317菌株,其培养上清液和从其分离的抗菌代谢物可有效地用于组合物,保健食品和益生菌,以抑制耐药性病原性微生物和肠致病性微生物的生长。对耐甲氧西林的致病微生物以及塔氏爱德华氏菌,大肠杆菌和表皮葡萄球菌等肠致病性微生物的生长具有优异的抗菌活性和抑制作用。

著录项

  • 公开/公告号KR100878799B1

    专利类型

  • 公开/公告日2009-01-14

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20070024566

  • 发明设计人 장영효;정민영;이문수;

    申请日2007-03-13

  • 分类号C12N1/20;C12N1;

  • 国家 KR

  • 入库时间 2022-08-21 19:12:17

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号